Montréal, March 19 2020 – Given the exceptional circumstances currently surrounding the COVID-19 pandemic and in compliance with the policies implemented by our governments, which have declared a state of health emergency, IRICoR management has decided to introduce certain temporary measures in order to reduce contact and the risk of transmission. To do so, all IRICoR staff members have been asked to continue their activities remotely whenever possible, to avoid non-essential travel for professional purposes and to cancel all participation in large meetings/conferences.

In this context of a major crisis, IRICoR salutes all of the research efforts being carried out to defeat this unprecedented epidemic and stresses the key role of scientific research, at the heart of our mission, which contributes to advancing the discovery of new therapies for the benefit of patients.

Dr Nadine Beauger, Chief Executive Officer, IRICoR


© 2008-2023 IRICoR